U.S. clinical-stage biopharmaceutical company resTORbio has completed its underwritten public offering of 7.2 million shares of its common stock at a price of $6.95 per share.
The company also granted the underwriters a 30-day option to buy up to an additional 1 million shares of common stock at the public offering price, less underwriting discounts and commissions.
The gross proceeds secured in the offering are around $50 million, excluding any exercise of the underwriters’ option to buy additional shares.
U.S. investment banks BofA Merrill Lynch, SVB Leerink and Guggenheim Securities acted as joint book-running managers for the deal.
17.09.2021 - Repligen Corporation, Avitide
United States - $ 150.000.000
17.09.2021 - Freddie Mac
United States - $ 1.300.000.000
17.09.2021 - Vincerx Pharma, Deerfield Management Company, Rock Springs Capital, Point72 Asset Management, Sphera Healthcare
United States - $ 50.000.000
17.09.2021 - CIT Group Inc.
United States - $ 41.600.000
17.09.2021 - Tetra Tech, Inc.
United States - $ 800.000.000
17.09.2021 - RIP Medical Debt, TransUnion Healthcare
United States - $ 5.000.000.000
17.09.2021 - aTyr Pharma
United States - $ 75.000.000
United States - $ 907.000.000
17.09.2021 - CleanSpark
United States - $ 145.000.000
17.09.2021 - Virpax Pharmaceuticals
United States - $ 40.020.000
17.09.2021 - Founders Properties, JLL Capital Markets
United States - $ 114.000.000
17.09.2021 - eMagin Corporation
United States - $ 33.600.000
17.09.2021 - JLL
United States - $ 250.000.000
17.09.2021 - iSun Energy, SolarCommunities
United States - $ 40.000.000
17.09.2021 - JLL Capital Markets
United States - $ 37.250.000
17.09.2021 - Fannie Mae, Pacific Investment Management
United States - $ 2.140.000.000
17.09.2021 - Archer Aviation, Atlas Crest Investment Corp.
United States - $ 857.600.000
17.09.2021 - Ranger Energy Services, Ranger Energy Acquisition, Basic Energy Services
United States - $ 36.650.000
17.09.2021 - RLJ Lodging Trust
United States - $ 225.000.000
17.09.2021 - Hercules Capital
United States - $ 325.000.000